[1] 杨立勇.关注糖尿病微血管并发症研究进展[J].中华糖尿病杂志,2016,8(8):449-451. [2] 李泽宇,刘栋,袁文明,等.糖尿病肾病危险因素及血压控制临界值研究[J].中国全科医学,2014(20):2325-2328. [3] R Lindblom,G Higgins,M Coughlan.Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy [J].Rev Diabetic Studies Rds,2015,12(1-2):134-156. [4] 曹丹,郝丽荣.糖尿病肾病与肾素-血管紧张素-醛固酮系统的关系[J].医学综述,2012,18(9):1386-1388. [5] 沈丽莎,李锦伟,黄珊,等.左旋氨氯地平联合氯沙坦治疗2型糖尿病肾病合并高血压的疗效及对血压和肾功能的影响[J].现代生物医学进展,2016,16(14):2695-2698. [6] 毕菲菲,姚岚,王敏,等.益气养阴活血通络方治疗糖尿病肾病疗效观察[J].陕西中医,2015,36(3):304-305. [7] AA Elmarakby,JC Sullivan.Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy [J].Cardiovasc Ther,2012,30(1):49-59. [8] A Mima.Inflammation and Oxidative Stress in Diabetic Nephropathy:New Insights on Its Inhibition as New Therapeutic Targets [J].J Diabetes Res,2013,2013(6):248563. [9] Wang JC,Zhao Y,Chen SJ.AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-κB pathway in rat mesangial cells:inhibition by sesquiterpene lactones [J].Cell Physiol Biochem,2013,32(6):1867-1877.
2018, Vol. 35 
